AustralieFrV1, Main, Exploration, bibRecord, 004009

Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive persons

Identifieur interne : 004009 ( Main/Exploration ); précédent : 004008; suivant : 004010

Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive persons

Auteurs : Lene Ryom [Danemark] ; Amanda Mocroft [Royaume-Uni] ; Ole Kirk [Danemark] ; Michael Ross [États-Unis] ; Peter Reiss [Pays-Bas] ; Christophe A. Fux [Suisse] ; Philippe Morlat [France] ; Olivier Moranne [France] ; Colette Smith [Royaume-Uni] ; Wafaa Ei-Sadr [États-Unis] ; Matthew Law [Australie] ; Jens D. Lundgren [Danemark]

Source :

AIDS : (London) [ 0269-9370 ] ; 2014.

RBID : Pascal:14-0119691

Descripteurs français

Pascal (Inist)
- Néphropathie chronique, SIDA, Ténofovir, Facteur prédictif, Stade avancé, Effet secondaire, Virus immunodéficience humaine, Toxicité, Antirétroviral, Antiviral, Insuffisance rénale chronique.

English descriptors

KwdEn :
- AIDS, Advanced stage, Antiretroviral agent, Antiviral, Chronic kidney disease, Chronic renal failure, Human immunodeficiency virus, Predictive factor, Secondary effect, Tenofovir, Toxicity.

Abstract

Objectives: Whilst several antiretroviral drugs have been associated with moderate chronic kidney disease (CKD), their contribution to advanced CKD and end-stage renal disease (ESRD) remain unknown. Design: D:A:D participants with at least three estimated glomerular filtration rates (eGFR) after February 2004 were followed until the first of advanced CKD (confirmed eGFR ≤ 30ml/min, ≥3 months apart), ESRD (dialysis ≥3 months/ transplantation), 6 months after last visit or February 2012. Methods: Poisson regression was used to assess risk factors for advanced CKD/ESRD including exposure to potential nephrotoxic antiretroviral drugs and antiretroviral drug discontinuation rates according to latest eGFR. Results: Among 35192 persons contributing 200119 person years of follow-up (PYFU), 135 (0.4%) developed advanced CKD (n = 114)/ESRD (n = 21); incidence rate = 0.67 [95% confidence interval (CI), 0.56-0.79]/1000 PYFU. Tenofovir (TDF) was particularly frequently discontinued as eGFR declined. After adjustment, those previously exposed but currently off TDF had similar advanced CKD/ESRD rate ratios compared with those unexposed [1.00 (95% CI, 0.66-1.51)], while those currently on TDF had reduced rates [0.23 (95% CI, 0.13-0.41)]. No consistent associations with other antiretroviral drugs were seen. Results were robust after time-lagging antiretroviral drug exposure, stratifying by baseline eGFR, and allowing for competing risks. Other predictors were diabetes, hypertension, baseline eGFR, smoking and current CD4⁺ cell count. The incidence rate in nonsmokers with baseline eGFR > 60 and no diabetes or hypertension was 0.16 (95% CI 0.09-0.26)/1000 PYFU.

Affiliations:

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: 000454
to stream PascalFrancis, to step Curation: 005A07
to stream PascalFrancis, to step Checkpoint: 000145
to stream Main, to step Merge: 004069
to stream Main, to step Curation: 004009

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive persons</title>
<author><name sortKey="Ryom, Lene" sort="Ryom, Lene" uniqKey="Ryom L" first="Lene" last="Ryom">Lene Ryom</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Copenhagen HIV Programme, University of Copenhagen, Faculty of Health and Medical Sciences and Epidemiklinikken M5132, Copenhagen University Hospital/Rigshospitalet</s1>
<s2>Copenhagen</s2>
<s3>DNK</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Danemark</country>
<placeName><settlement type="city">Copenhague</settlement>
<region type="région" nuts="2">Hovedstaden</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mocroft, Amanda" sort="Mocroft, Amanda" uniqKey="Mocroft A" first="Amanda" last="Mocroft">Amanda Mocroft</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Research Department of Infection and Population Health, UCL</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kirk, Ole" sort="Kirk, Ole" uniqKey="Kirk O" first="Ole" last="Kirk">Ole Kirk</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Copenhagen HIV Programme, University of Copenhagen, Faculty of Health and Medical Sciences and Epidemiklinikken M5132, Copenhagen University Hospital/Rigshospitalet</s1>
<s2>Copenhagen</s2>
<s3>DNK</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Danemark</country>
<placeName><settlement type="city">Copenhague</settlement>
<region type="région" nuts="2">Hovedstaden</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ross, Michael" sort="Ross, Michael" uniqKey="Ross M" first="Michael" last="Ross">Michael Ross</name>
<affiliation wicri:level="2"><inist:fA14 i1="03"><s1>Division of Nephrology, Mount Sinai School of Medicine</s1>
<s2>New York</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Reiss, Peter" sort="Reiss, Peter" uniqKey="Reiss P" first="Peter" last="Reiss">Peter Reiss</name>
<affiliation wicri:level="4"><inist:fA14 i1="04"><s1>Academic Medical Center, University of Amsterdam, and Stichting HIV Monitoring</s1>
<s3>NLD</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
<wicri:noRegion>Academic Medical Center, University of Amsterdam, and Stichting HIV Monitoring</wicri:noRegion>
<orgName type="university">Université d'Amsterdam</orgName>
<placeName><settlement type="city">Amsterdam</settlement>
<region>Hollande-Septentrionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fux, Christophe A" sort="Fux, Christophe A" uniqKey="Fux C" first="Christophe A." last="Fux">Christophe A. Fux</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Clinic for Infectious Diseases and Hospital Hygiene, Kantonsspital Aarau</s1>
<s3>CHE</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
<wicri:noRegion>Clinic for Infectious Diseases and Hospital Hygiene, Kantonsspital Aarau</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Morlat, Philippe" sort="Morlat, Philippe" uniqKey="Morlat P" first="Philippe" last="Morlat">Philippe Morlat</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Service de médecine interne et maladies infectieuses, Hôpital Saint-André, CHU de Bordeaux</s1>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<wicri:noRegion>CHU de Bordeaux</wicri:noRegion>
<wicri:noRegion>Service de médecine interne et maladies infectieuses, Hôpital Saint-André, CHU de Bordeaux</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Moranne, Olivier" sort="Moranne, Olivier" uniqKey="Moranne O" first="Olivier" last="Moranne">Olivier Moranne</name>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Nephrology Department, Public Health Department, CHU Nice</s1>
<s3>FRA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
<wicri:noRegion>CHU Nice</wicri:noRegion>
<wicri:noRegion>Nephrology Department, Public Health Department, CHU Nice</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Smith, Colette" sort="Smith, Colette" uniqKey="Smith C" first="Colette" last="Smith">Colette Smith</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Research Department of Infection and Population Health, UCL</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ei Sadr, Wafaa" sort="Ei Sadr, Wafaa" uniqKey="Ei Sadr W" first="Wafaa" last="Ei-Sadr">Wafaa Ei-Sadr</name>
<affiliation wicri:level="2"><inist:fA14 i1="08"><s1>ICAP-Columbia University and Harlem Hospital</s1>
<s2>New York</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Law, Matthew" sort="Law, Matthew" uniqKey="Law M" first="Matthew" last="Law">Matthew Law</name>
<affiliation wicri:level="3"><inist:fA14 i1="09"><s1>Kirby Institute</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<placeName><settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lundgren, Jens D" sort="Lundgren, Jens D" uniqKey="Lundgren J" first="Jens D." last="Lundgren">Jens D. Lundgren</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Copenhagen HIV Programme, University of Copenhagen, Faculty of Health and Medical Sciences and Epidemiklinikken M5132, Copenhagen University Hospital/Rigshospitalet</s1>
<s2>Copenhagen</s2>
<s3>DNK</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Danemark</country>
<placeName><settlement type="city">Copenhague</settlement>
<region type="région" nuts="2">Hovedstaden</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">14-0119691</idno>
<date when="2014">2014</date>
<idno type="stanalyst">PASCAL 14-0119691 INIST</idno>
<idno type="RBID">Pascal:14-0119691</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000454</idno>
<idno type="wicri:Area/PascalFrancis/Curation">005A07</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000145</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000145</idno>
<idno type="wicri:doubleKey">0269-9370:2014:Ryom L:predictors:of:advanced</idno>
<idno type="wicri:Area/Main/Merge">004069</idno>
<idno type="wicri:Area/Main/Curation">004009</idno>
<idno type="wicri:Area/Main/Exploration">004009</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive persons</title>
<author><name sortKey="Ryom, Lene" sort="Ryom, Lene" uniqKey="Ryom L" first="Lene" last="Ryom">Lene Ryom</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Copenhagen HIV Programme, University of Copenhagen, Faculty of Health and Medical Sciences and Epidemiklinikken M5132, Copenhagen University Hospital/Rigshospitalet</s1>
<s2>Copenhagen</s2>
<s3>DNK</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Danemark</country>
<placeName><settlement type="city">Copenhague</settlement>
<region type="région" nuts="2">Hovedstaden</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mocroft, Amanda" sort="Mocroft, Amanda" uniqKey="Mocroft A" first="Amanda" last="Mocroft">Amanda Mocroft</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Research Department of Infection and Population Health, UCL</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kirk, Ole" sort="Kirk, Ole" uniqKey="Kirk O" first="Ole" last="Kirk">Ole Kirk</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Copenhagen HIV Programme, University of Copenhagen, Faculty of Health and Medical Sciences and Epidemiklinikken M5132, Copenhagen University Hospital/Rigshospitalet</s1>
<s2>Copenhagen</s2>
<s3>DNK</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Danemark</country>
<placeName><settlement type="city">Copenhague</settlement>
<region type="région" nuts="2">Hovedstaden</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ross, Michael" sort="Ross, Michael" uniqKey="Ross M" first="Michael" last="Ross">Michael Ross</name>
<affiliation wicri:level="2"><inist:fA14 i1="03"><s1>Division of Nephrology, Mount Sinai School of Medicine</s1>
<s2>New York</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Reiss, Peter" sort="Reiss, Peter" uniqKey="Reiss P" first="Peter" last="Reiss">Peter Reiss</name>
<affiliation wicri:level="4"><inist:fA14 i1="04"><s1>Academic Medical Center, University of Amsterdam, and Stichting HIV Monitoring</s1>
<s3>NLD</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
<wicri:noRegion>Academic Medical Center, University of Amsterdam, and Stichting HIV Monitoring</wicri:noRegion>
<orgName type="university">Université d'Amsterdam</orgName>
<placeName><settlement type="city">Amsterdam</settlement>
<region>Hollande-Septentrionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fux, Christophe A" sort="Fux, Christophe A" uniqKey="Fux C" first="Christophe A." last="Fux">Christophe A. Fux</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Clinic for Infectious Diseases and Hospital Hygiene, Kantonsspital Aarau</s1>
<s3>CHE</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
<wicri:noRegion>Clinic for Infectious Diseases and Hospital Hygiene, Kantonsspital Aarau</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Morlat, Philippe" sort="Morlat, Philippe" uniqKey="Morlat P" first="Philippe" last="Morlat">Philippe Morlat</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Service de médecine interne et maladies infectieuses, Hôpital Saint-André, CHU de Bordeaux</s1>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<wicri:noRegion>CHU de Bordeaux</wicri:noRegion>
<wicri:noRegion>Service de médecine interne et maladies infectieuses, Hôpital Saint-André, CHU de Bordeaux</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Moranne, Olivier" sort="Moranne, Olivier" uniqKey="Moranne O" first="Olivier" last="Moranne">Olivier Moranne</name>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Nephrology Department, Public Health Department, CHU Nice</s1>
<s3>FRA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
<wicri:noRegion>CHU Nice</wicri:noRegion>
<wicri:noRegion>Nephrology Department, Public Health Department, CHU Nice</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Smith, Colette" sort="Smith, Colette" uniqKey="Smith C" first="Colette" last="Smith">Colette Smith</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Research Department of Infection and Population Health, UCL</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ei Sadr, Wafaa" sort="Ei Sadr, Wafaa" uniqKey="Ei Sadr W" first="Wafaa" last="Ei-Sadr">Wafaa Ei-Sadr</name>
<affiliation wicri:level="2"><inist:fA14 i1="08"><s1>ICAP-Columbia University and Harlem Hospital</s1>
<s2>New York</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Law, Matthew" sort="Law, Matthew" uniqKey="Law M" first="Matthew" last="Law">Matthew Law</name>
<affiliation wicri:level="3"><inist:fA14 i1="09"><s1>Kirby Institute</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<placeName><settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lundgren, Jens D" sort="Lundgren, Jens D" uniqKey="Lundgren J" first="Jens D." last="Lundgren">Jens D. Lundgren</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Copenhagen HIV Programme, University of Copenhagen, Faculty of Health and Medical Sciences and Epidemiklinikken M5132, Copenhagen University Hospital/Rigshospitalet</s1>
<s2>Copenhagen</s2>
<s3>DNK</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Danemark</country>
<placeName><settlement type="city">Copenhague</settlement>
<region type="région" nuts="2">Hovedstaden</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">AIDS : (London)</title>
<title level="j" type="abbreviated">AIDS : (Lond.)</title>
<idno type="ISSN">0269-9370</idno>
<imprint><date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">AIDS : (London)</title>
<title level="j" type="abbreviated">AIDS : (Lond.)</title>
<idno type="ISSN">0269-9370</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>AIDS</term>
<term>Advanced stage</term>
<term>Antiretroviral agent</term>
<term>Antiviral</term>
<term>Chronic kidney disease</term>
<term>Chronic renal failure</term>
<term>Human immunodeficiency virus</term>
<term>Predictive factor</term>
<term>Secondary effect</term>
<term>Tenofovir</term>
<term>Toxicity</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Néphropathie chronique</term>
<term>SIDA</term>
<term>Ténofovir</term>
<term>Facteur prédictif</term>
<term>Stade avancé</term>
<term>Effet secondaire</term>
<term>Virus immunodéficience humaine</term>
<term>Toxicité</term>
<term>Antirétroviral</term>
<term>Antiviral</term>
<term>Insuffisance rénale chronique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Objectives: Whilst several antiretroviral drugs have been associated with moderate chronic kidney disease (CKD), their contribution to advanced CKD and end-stage renal disease (ESRD) remain unknown. Design: D:A:D participants with at least three estimated glomerular filtration rates (eGFR) after February 2004 were followed until the first of advanced CKD (confirmed eGFR ≤ 30ml/min, ≥3 months apart), ESRD (dialysis ≥3 months/ transplantation), 6 months after last visit or February 2012. Methods: Poisson regression was used to assess risk factors for advanced CKD/ESRD including exposure to potential nephrotoxic antiretroviral drugs and antiretroviral drug discontinuation rates according to latest eGFR. Results: Among 35192 persons contributing 200119 person years of follow-up (PYFU), 135 (0.4%) developed advanced CKD (n = 114)/ESRD (n = 21); incidence rate = 0.67 [95% confidence interval (CI), 0.56-0.79]/1000 PYFU. Tenofovir (TDF) was particularly frequently discontinued as eGFR declined. After adjustment, those previously exposed but currently off TDF had similar advanced CKD/ESRD rate ratios compared with those unexposed [1.00 (95% CI, 0.66-1.51)], while those currently on TDF had reduced rates [0.23 (95% CI, 0.13-0.41)]. No consistent associations with other antiretroviral drugs were seen. Results were robust after time-lagging antiretroviral drug exposure, stratifying by baseline eGFR, and allowing for competing risks. Other predictors were diabetes, hypertension, baseline eGFR, smoking and current CD4<sup>+</sup>
 cell count. The incidence rate in nonsmokers with baseline eGFR > 60 and no diabetes or hypertension was 0.16 (95% CI 0.09-0.26)/1000 PYFU.</div>
</front>
</TEI>
<affiliations><list><country><li>Australie</li>
<li>Danemark</li>
<li>France</li>
<li>Pays-Bas</li>
<li>Royaume-Uni</li>
<li>Suisse</li>
<li>États-Unis</li>
</country>
<region><li>Angleterre</li>
<li>Grand Londres</li>
<li>Hollande-Septentrionale</li>
<li>Hovedstaden</li>
<li>Nouvelle-Galles du Sud</li>
<li>État de New York</li>
</region>
<settlement><li>Amsterdam</li>
<li>Copenhague</li>
<li>Londres</li>
<li>Sydney</li>
</settlement>
<orgName><li>Université d'Amsterdam</li>
</orgName>
</list>
<tree><country name="Danemark"><region name="Hovedstaden"><name sortKey="Ryom, Lene" sort="Ryom, Lene" uniqKey="Ryom L" first="Lene" last="Ryom">Lene Ryom</name>
</region>
<name sortKey="Kirk, Ole" sort="Kirk, Ole" uniqKey="Kirk O" first="Ole" last="Kirk">Ole Kirk</name>
<name sortKey="Lundgren, Jens D" sort="Lundgren, Jens D" uniqKey="Lundgren J" first="Jens D." last="Lundgren">Jens D. Lundgren</name>
</country>
<country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Mocroft, Amanda" sort="Mocroft, Amanda" uniqKey="Mocroft A" first="Amanda" last="Mocroft">Amanda Mocroft</name>
</region>
<name sortKey="Smith, Colette" sort="Smith, Colette" uniqKey="Smith C" first="Colette" last="Smith">Colette Smith</name>
</country>
<country name="États-Unis"><region name="État de New York"><name sortKey="Ross, Michael" sort="Ross, Michael" uniqKey="Ross M" first="Michael" last="Ross">Michael Ross</name>
</region>
<name sortKey="Ei Sadr, Wafaa" sort="Ei Sadr, Wafaa" uniqKey="Ei Sadr W" first="Wafaa" last="Ei-Sadr">Wafaa Ei-Sadr</name>
</country>
<country name="Pays-Bas"><region name="Hollande-Septentrionale"><name sortKey="Reiss, Peter" sort="Reiss, Peter" uniqKey="Reiss P" first="Peter" last="Reiss">Peter Reiss</name>
</region>
</country>
<country name="Suisse"><noRegion><name sortKey="Fux, Christophe A" sort="Fux, Christophe A" uniqKey="Fux C" first="Christophe A." last="Fux">Christophe A. Fux</name>
</noRegion>
</country>
<country name="France"><noRegion><name sortKey="Morlat, Philippe" sort="Morlat, Philippe" uniqKey="Morlat P" first="Philippe" last="Morlat">Philippe Morlat</name>
</noRegion>
<name sortKey="Moranne, Olivier" sort="Moranne, Olivier" uniqKey="Moranne O" first="Olivier" last="Moranne">Olivier Moranne</name>
</country>
<country name="Australie"><region name="Nouvelle-Galles du Sud"><name sortKey="Law, Matthew" sort="Law, Matthew" uniqKey="Law M" first="Matthew" last="Law">Matthew Law</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004009 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004009 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:14-0119691
   |texte=   Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive persons
}}

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive persons

Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive persons

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri